Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 3

Status

Completed 29Active not recruiting 8Unknown 7Recruiting 6Terminated 5Not yet recruiting 1

Sponsor Class

OTHER 6NIH 1

Study Type

Interventional 7

Sponsor

Cancer Type

Lymphoid 7

Conditions

Melanoma 7Hodgkin Disease 7Neoplasm Metastasis 3Lymphoma 3Recurrence 2Neuroblastoma 2Neuroendocrine Tumors 1

Interventions

Cyclophosphamide 12Etoposide 10Doxorubicin 9Brentuximab Vedotin 8fludarabine phosphate 7Vinblastine 7Dacarbazine 7Bleomycin 7Vincristine 6Melphalan 6camrelizumab 5Radiotherapy 5Nivolumab 5Mycophenolic Acid 5Decitabine 5pembrolizumab 4Rituximab 4Peripheral Blood Stem Cell Transplantation 4Gemcitabine 4Filgrastim 4Cytarabine 4Cyclosporine 4Busulfan 4Bendamustine Hydrochloride 4ABVD protocol 4Tacrolimus 3Prednisone 3N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Ifosfamide 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × Hodgkin Disease × Dacarbazine × Clear all
NCT06201507 2024-01-12

BV-AVD-R Treatment Children Hodgkin's Lymphoma

Beijing Children's Hospital

Phase 2 Unknown
44 enrolled
Lymphoid

Hodgkin Disease

NCT03226249 2023-06-02

PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma

Northwestern University

Phase 2 Unknown
30 enrolled 10 charts
Lymphoid

Hodgkin Disease

NCT00736320 2020-11-04

HD16

University of Cologne

Phase 3 Unknown
1,150 enrolled
Lymphoid

Hodgkin Disease

NCT03527628 2019-11-18

(Optimist)

King Abdullah International Medical Research Center

Phase 2 Unknown
220 enrolled
Lymphoid

Hodgkin Disease

NCT00041210 2013-09-20

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
850 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00797472 2011-07-20

Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease

American Scitech International

Phase 2 Unknown
120 enrolled
Lymphoid

Hodgkin Disease

NCT00816959 2011-07-20

Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

American Scitech International

Phase 3 Unknown
1,200 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡